Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

A CLL (Chronic Lymphocytic Leukemia) Patient Tells Her Story About Being Immune Compromised During the COVID-19 Pandemic and Accessing Regen-Cov (Casirivimab and Imdevimab) for Protection

This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.

For CLL/SLL patients, many of whom lived pretty everyday lives despite having incurable cancer, the COVID-19 pandemic changed everything by shining a light on the vulnerability of the immunocompromised.

Jill Gollinger, a CLL patient, wrote this article for her local community magazine about her push to get accepted into the Compassionate Use Program to prevent COVID-19 by receiving monthly infusions of Regen-Cov. She is hoping to avoid the same fearful news as Jill received. To learn more about Regeneron’s robust Compassionate Use Program, click here.

We learn from this intelligent and brave patient how COVID turned over her lives and her reactions to the threat.

Please, if you haven’t already, review, complete, and print our COVID ACTION PLAN. It could be lifesaving.

Stay strong.  We are all in this together.

Brian

Brian Koffman MDCM (retired) MS Ed (he, him, his)
Co-Founder, Executive VP and Chief Medical Officer
CLL Society, Inc.